Last Updated: August 2, 2026

AMINOACETIC ACID 1.5% IN PLASTIC CONTAINER Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Aminoacetic Acid 1.5% In Plastic Container, and what generic alternatives are available?

Aminoacetic Acid 1.5% In Plastic Container is a drug marketed by Baxter Hlthcare and is included in one NDA.

The generic ingredient in AMINOACETIC ACID 1.5% IN PLASTIC CONTAINER is glycine. There are thirty drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the glycine profile page.

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for AMINOACETIC ACID 1.5% IN PLASTIC CONTAINER?
  • What are the global sales for AMINOACETIC ACID 1.5% IN PLASTIC CONTAINER?
  • What is Average Wholesale Price for AMINOACETIC ACID 1.5% IN PLASTIC CONTAINER?
Summary for AMINOACETIC ACID 1.5% IN PLASTIC CONTAINER
US Patents:0
Applicants:1
NDAs:1

US Patents and Regulatory Information for AMINOACETIC ACID 1.5% IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare AMINOACETIC ACID 1.5% IN PLASTIC CONTAINER glycine SOLUTION;IRRIGATION 017865-001 Approved Prior to Jan 1, 1982 AT RX Yes Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Investment Scenario and Fundamentals Analysis for Aminoacetic Acid 1.5% in Plastic Container

Last updated: February 26, 2026

What is the Market and Application of Aminoacetic Acid 1.5%?

Aminoacetic acid, commonly known as glycine, is an amino acid with applications mainly in pharmaceuticals, dietary supplements, and industrial uses such as feed additives. The 1.5% concentration in a plastic container indicates a form targeted for either medical, cosmetic, or food-grade applications.

Market Overview

  • Size and Growth: The global amino acids market was valued at approximately USD 10.5 billion in 2022, growing at a compound annual growth rate (CAGR) of 7.2%, projected to reach USD 16 billion by 2028 (Fortune Business Insights, 2023).
  • Key End-Uses: Food supplements (40%), pharmaceuticals (30%), feed additives (15%), other industrial applications (15%).
  • Geography: North America and Asia-Pacific hold significant shares, driven by healthcare spending and food industry expansion.

Product Position and Differentiation

  • The specific formulation—1.5% aminoacetic acid in a plastic container—targets segment-specific applications such as topical formulations, oral solutions, or industrial usage.
  • Packaging: Plastic containers ensure stability, ease of handling, and low cost, suitable for scalable production.

Competitive Landscape

Company Key Products Market Share Focus Area
Ajinomoto Amino acids 18% Food and beverage, pharmaceuticals
Evonik Industries Specialty amino acids 12% Industrial, biomedical applications
Kyowa Hakko Kirin Amino acids 10% Nutritional, medical applications
Others Various 60% Diversified producers

Development and Approvals

  • Glycine, the active ingredient, holds Generally Recognized As Safe (GRAS) status for food use.
  • Regulatory approvals depend on regional authorities: FDA (US), EMA (Europe), and CFDA (China).

Manufacturing and Supply Chain

  • Raw materials include synthesis precursors and downstream refining processes.
  • Manufacturing costs are influenced by feedstock prices, energy, and regulatory compliance.
  • Supply chain integrity and stability are vital to maintain pricing and meet demand.

Cost Structure & Pricing

Cost Component Percentage of product cost Notes
Raw materials 40-50% Aminoacetic acid synthesis precursors
Manufacturing overhead 20-25% Equipment, labor, quality controls
Packaging 5-10% Plastic container production and filling
Distribution & logistics 10-15% Shipping, customs, warehousing
Margin 10-15% Variable based on buyer and market conditions

Pricing varies by end-use, geography, and volume—estimated retail price USD 3-5 per 100 grams for pharmaceutical-grade solutions.

Regulatory and Legal Landscape

  • Regulations restrict certain uses of amino acids in food, pharmaceuticals, and industrial applications.
  • Patent status: Active patents may restrict generic manufacturing; however, glycine patents are largely expired or near expiry.

Investment Considerations

Strengths

  • Growing amino acid market driven by health and nutrition trends.
  • Existing regulatory approval for food and pharma segments enhances market entry prospects.
  • Cost-effective manufacturing with established supply chains.

Risks

  • Market saturation with multiple suppliers; price competition.
  • Regulatory shifts could impact manufacturing or usage permissions.
  • Raw material supply fluctuations affect costs and production timelines.

Opportunities

  • Expansion into niche pharmaceutical or cosmetic applications.
  • Development of stabilized formulations with improved shelf-life.
  • Breakthroughs in biotechnological synthesis lowering production costs.

Key Metrics to Monitor

  • Price dynamics in aminoacetic acid markets.
  • Regulatory approvals in targeted markets.
  • Patent expiry dates affecting generic competition.
  • Product procurement volume trends across end-user sectors.

Final Assessment

Investing in aminoacetic acid 1.5% in a plastic container aligns with rising demand in health, nutrition, and industrial segments. The fundamental landscape prospects favor scale-up, provided companies navigate regulatory hurdles and price competition efficiently.


Key Takeaways

  • The global amino acids market, valued at USD 10.5 billion in 2022, is expanding with a CAGR of 7.2%.
  • Glycine, as a core amino acid, benefits from broad applications and regulatory acceptance.
  • Market entry depends on sourcing raw materials, managing costs, and securing regulatory approvals.
  • Price volatility and competition pose ongoing risks.
  • Opportunities exist in niche applications and formulation innovations.

FAQs

  1. What are primary end-use markets for aminoacetic acid 1.5%?
    Food additives, pharmaceuticals, dietary supplements, and industrial applications.

  2. How does patent status affect investment?
    Many patents on glycine-related processes have expired, facilitating generics but increasing competition.

  3. What are key regulatory hurdles?
    Ensuring compliance with health safety standards, certifications like FDA GRAS, and regional labeling laws.

  4. What factors influence raw material costs?
    Feedstock prices, energy costs, and supply chain stability.

  5. Is demand expected to grow in emerging markets?
    Yes; increased urbanization and health awareness drive demand in Asia-Pacific, Africa, and Latin America.


References

[1] Fortune Business Insights. (2023). Amino acids market size, share, growth. Retrieved from https://www.fortunebusinessinsights.com/industry-reports/amino-acids-market-102850

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.